Live Marvell Technology Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow KESTRA MEDICAL TECHNOLOGIES, LTD.

Get SEC filing alerts via email and in your feed for KESTRA MEDICAL TECHNOLOGIES, LTD.

KMTS

KESTRA MEDICAL TECHNOLOGIES, LTD.

About KESTRA MEDICAL TECHNOLOGIES, LTD.

Kestra Medical Technologies develops and commercializes advanced wearable cardioverter defibrillators (WCDs) and digital health solutions for cardiac patients at risk of sudden cardiac arrest. Its flagship product, the ASSURE WCD, offers improved comfort, accuracy, and connectivity, targeting hospitals and healthcare providers worldwide. The company’s integrated platform enhances patient compliance, supports clinical decision-making, and aims to expand market share in a growing, underpenetrated global cardiac care market.
This description was generated via AI from an annual report. Updated 8 months ago.

Latest SEC Filings from KESTRA MEDICAL TECHNOLOGIES, LTD.

1
1
KESTRA MEDICAL TECHNOLOGIES, LTD. Kestra Medical Technologies Reports 63% Revenue Growth but Increased Net Loss in Latest Quarter

Via official filing (AI summary) | 3 months ago | 0 comments

2
1
KESTRA MEDICAL TECHNOLOGIES, LTD. Kestra Medical Technologies Reports 53% Revenue Growth but Faces Increased Net Loss

Via official filing (AI summary) | 6 months ago | 0 comments

3
1
KESTRA MEDICAL TECHNOLOGIES, LTD. Kestra Medical Technologies Reports 52% Revenue Growth to $19.4 Million Despite Increased Net Loss

Via official filing (AI summary) | 9 months ago | 0 comments

4
1
KESTRA MEDICAL TECHNOLOGIES, LTD. Kestra Medical Technologies Reports 115% Revenue Growth to $59.8 Million in Fiscal Year 2025

Via official filing (AI summary) | 11 months ago | 0 comments